Explore the dual role of SMAD4 in hepatocellular carcinoma - from tumor suppressor to tumor promoter in liver cancer development.
Discover how engineered bacteria and nanoparticles combine in a revolutionary triple-strategy system to combat hepatocellular carcinoma with unprecedented precision.
Sirtex Medical's SIR-Spheres Y-90 resin microspheres receive FDA approval for hepatocellular carcinoma treatment, marking a breakthrough in targeted radiation therapy.
Explore how biomimetic nanoparticles are transforming liver cancer treatment through targeted drug delivery and immune evasion capabilities.
Explore how organoid biotechnology is transforming liver cancer research through personalized 3D models that mimic human liver tumors for advanced drug testing and treatment development.